{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:57:49Z","timestamp":1732042669434},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.virol.2023.04.008","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T23:54:44Z","timestamp":1682207684000},"page":"36-44","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Humanization and characterization of a murine monoclonal neutralizing antibody against human adenovirus 7"],"prefix":"10.1016","volume":"583","author":[{"given":"Lei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiansheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2023.04.008_bib1","doi-asserted-by":"crossref","first-page":"W537","DOI":"10.1093\/nar\/gks375","article-title":"H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations","volume":"40","author":"Anandakrishnan","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2023.04.008_bib2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.15585\/mmwr.mm6639a2","article-title":"Human adenovirus surveillance - United States, 2003-2016","volume":"66","author":"Binder","year":"2017","journal-title":"MMWR. Morbidity and mortality weekly report"},{"key":"10.1016\/j.virol.2023.04.008_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0042-6822(81)90208-7","article-title":"Antibody-triggered dissociation of adenovirus penton capsomer","volume":"113","author":"Boudin","year":"1981","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.04.008_bib4","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1128\/AAC.04348-14","article-title":"Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients","volume":"59","author":"Caruso Brown","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2023.04.008_bib5","doi-asserted-by":"crossref","first-page":"S2280","DOI":"10.21037\/jtd.2018.03.168","article-title":"Vaccine development for human mastadenovirus","volume":"10","author":"Chen","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.virol.2023.04.008_bib6","first-page":"2331","article-title":"Epidemiology and transmission characteristics of human adenovirus type 7 caused acute respiratory disease outbreak in military trainees in East China","volume":"8","author":"Cheng","year":"2016","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.virol.2023.04.008_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ymeth.2005.01.005","article-title":"Antibody humanization by framework shuffling","volume":"36","author":"Dall'Acqua","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.virol.2023.04.008_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105034","article-title":"Emerging antiviral therapeutics for human adenovirus infection: recent developments and novel strategies","volume":"188","author":"Dodge","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2023.04.008_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-586-6_2","article-title":"Technical and ethical limitations in making human monoclonal antibodies (an overview)","volume":"1060","author":"Glassy","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2023.04.008_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/fcp.12609","article-title":"Antiviral therapies: advances and perspectives","volume":"35","author":"Goncalves","year":"2021","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.virol.2023.04.008_bib11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/prot.23246","article-title":"A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach","volume":"80","author":"Haidar","year":"2012","journal-title":"Proteins"},{"key":"10.1016\/j.virol.2023.04.008_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymeth.2005.01.004","article-title":"Use of human germline genes in a CDR homology-based approach to antibody humanization","volume":"36","author":"Hwang","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.virol.2023.04.008_bib13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virol.2023.04.008_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymeth.2005.01.003","article-title":"SDR grafting--a new approach to antibody humanization","volume":"36","author":"Kashmiri","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.virol.2023.04.008_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/hyb.1995.14.461","article-title":"Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49","volume":"14","author":"Kashmiri","year":"1995","journal-title":"Hybridoma"},{"key":"10.1016\/j.virol.2023.04.008_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4939-8648-4_3","article-title":"Use of IMGT((R)) databases and tools for antibody engineering and humanization","volume":"1827","author":"Lefranc","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2023.04.008_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10822-010-9395-8","article-title":"Computer-aided drug design platform using PyMOL","volume":"25","author":"Lill","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.virol.2023.04.008_bib18","article-title":"Outbreak of acute respiratory disease caused by human adenovirus type 7 and human coronavirus-229E in Zhejiang Province, China","volume":"95","author":"Liu","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2023.04.008_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2022.09.007","article-title":"A human monoclonal antibody to neutralize all four serotypes of dengue virus derived from patients at the convalescent phase of infection","volume":"576","author":"Lu","year":"2022","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.04.008_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2019.12.005","article-title":"A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein","volume":"543","author":"Lu","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.04.008_bib21","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.drudis.2015.07.007","article-title":"Antiadenovirus drug discovery: potential targets and evaluation methodologies","volume":"20","author":"Martinez-Aguado","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.virol.2023.04.008_bib22","first-page":"251","article-title":"A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words","volume":"48","author":"Mirick","year":"2004","journal-title":"Q. J. Nucl. Med. Mol. Imag. : official pub. Italian Assoc. Nuclear Med."},{"key":"10.1016\/j.virol.2023.04.008_bib23","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.virol.2023.04.008_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/02648725.2013.801235","article-title":"Antibody humanization methods - a review and update","volume":"29","author":"Safdari","year":"2013","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.virol.2023.04.008_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8091284","article-title":"Recent advances in novel antiviral therapies against human adenovirus","volume":"8","author":"Saha","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.virol.2023.04.008_bib26","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1021\/acs.jctc.7b00001","article-title":"Critical comparison of biomembrane force fields: protein-lipid interactions at the membrane interface","volume":"13","author":"Sandoval-Perez","year":"2017","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.virol.2023.04.008_bib27","first-page":"305","article-title":"A CDR-grafted (humanized) domain-deleted antitumor antibody","volume":"12","author":"Slavin-Chiorini","year":"1997","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.virol.2023.04.008_bib28","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1128\/JVI.00557-08","article-title":"Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport","volume":"82","author":"Smith","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.04.008_bib29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jmb.2016.08.019","article-title":"abYsis: integrated antibody sequence and structure-management, analysis, and prediction","volume":"429","author":"Swindells","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2023.04.008_bib30","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1038\/s41598-022-07952-4","article-title":"First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants","volume":"12","author":"Titong","year":"2022","journal-title":"Sci. Rep."},{"issue":"Pt 6","key":"10.1016\/j.virol.2023.04.008_bib31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1099\/0022-1317-73-6-1429","article-title":"Antipeptide antisera define neutralizing epitopes on the adenovirus hexon","volume":"73","author":"Toogood","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2023.04.008_bib32","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1128\/JVI.78.22.12320-12332.2004","article-title":"Postentry neutralization of adenovirus type 5 by an antihexon antibody","volume":"78","author":"Varghese","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.04.008_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-8958-4_1","article-title":"Human monoclonal antibodies: the benefits of humanization","volume":"1904","author":"Waldmann","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2023.04.008_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fcimb.2019.00417","article-title":"A murine monoclonal antibody with potent neutralization ability against human adenovirus 7","volume":"9","author":"Wang","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virol.2023.04.008_bib35","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/jvi.62.7.2321-2328.1988","article-title":"Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms","volume":"62","author":"Wohlfart","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.04.008_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-62703-586-6_5","article-title":"Polyclonal and monoclonal antibodies in clinic","volume":"1060","author":"Wootla","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2023.04.008_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7883\/yoken.67.105","article-title":"Impact of human adenovirus serotype 7 in hospitalized children with severe fatal pneumonia in the Philippines","volume":"67","author":"Yamamoto","year":"2014","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.virol.2023.04.008_bib38","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2023.04.008_bib39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.molimm.2009.10.028","article-title":"A germline knowledge based computational approach for determining antibody complementarity determining regions","volume":"47","author":"Zhao","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.virol.2023.04.008_bib40","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1038\/srep07365","article-title":"Re-emergent human adenovirus genome type 7d caused an acute respiratory disease outbreak in Southern China after a twenty-one year absence","volume":"4","author":"Zhao","year":"2014","journal-title":"Sci. Rep."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T15:45:37Z","timestamp":1717256737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682223000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":40,"alternative-id":["S0042682223000909"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2023.04.008","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humanization and characterization of a murine monoclonal neutralizing antibody against human adenovirus 7","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2023.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}